Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.
Cell Microsystems has raised $6.5M in total funding. The most recent round was Series B. The last funding was announced in August 2023.
Cell Microsystems's investors include National Institutes of Health, Telegraph Hill Partners, NC IDEA, Small Business Innovation Research.
Cell Microsystems is headquartered in Durham, United States.
Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.
Cell Microsystems is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cell Microsystems — Funding & Investors." VCBacked, August 23, 2023, https://www.vcbacked.co/company/cell-microsystems. Accessed July 20, 2026.
VCBacked. (2023). Cell Microsystems — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cell-microsystems
{{cite web |title=Cell Microsystems — Funding & Investors |url=https://www.vcbacked.co/company/cell-microsystems |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated